カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のがん焼灼療法機器市場2022年：冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション

◆英語タイトル：Global Cancer Ablation Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY7679 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：110 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

がん焼灼療法機器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のがん焼灼療法機器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

がん焼灼療法機器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション

用途別セグメントは次のように区分されます。
・脳がん、褐色、結腸直腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん

世界のがん焼灼療法機器市場の主要な市場プレーヤーは以下のとおりです。
・Alfresa Pharma Corp.、AngioDynamics, Inc.、BTG plc (Galil Medical Ltd./Perseon Medical)、Biomedical S.r.l.、Boston Scientific Corporation、CSA Medical, Inc.、Chongqing Haifu Medical Technology Co., Ltd、ECO Medical、EDAP TMS S.A.、HS Hospital Service S.p.A.、IceCure Medical, Inc.、Johnson & Johnson (Ethicon, Inc.)、Kang-Yu Medical Co., Ltd.、MedLink Technologies LLC、MedWaves, Inc.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、がん焼灼療法機器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要ながん焼灼療法機器メーカーの企業概要、2019年～2022年までのがん焼灼療法機器の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要ながん焼灼療法機器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別がん焼灼療法機器の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのがん焼灼療法機器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのがん焼灼療法機器市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびがん焼灼療法機器の産業チェーンを掲載しています。
・第13、14、15章では、がん焼灼療法機器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Alfresa Pharma Corp.、AngioDynamics, Inc.、BTG plc (Galil Medical Ltd./Perseon Medical)、Biomedical S.r.l.、Boston Scientific Corporation、CSA Medical, Inc.、Chongqing Haifu Medical Technology Co., Ltd、ECO Medical、EDAP TMS S.A.、HS Hospital Service S.p.A.、IceCure Medical, Inc.、Johnson & Johnson (Ethicon, Inc.)、Kang-Yu Medical Co., Ltd.、MedLink Technologies LLC、MedWaves, Inc.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション
・用途別分析2017年-2028年：脳がん、褐色、結腸直腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん
・がん焼灼療法機器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・がん焼灼療法機器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・がん焼灼療法機器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・がん焼灼療法機器の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・がん焼灼療法機器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cancer Ablation Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Ablation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Brain Cancer accounting for % of the Cancer Ablation Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cryoablation segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Ablation Devices include Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), Biomedical S.r.l., and Boston Scientific Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Ablation Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cryoablation
High-Intensity Focused Ultrasound (HIFU)
Laser Interstitial Thermal Therapy (LiTT)
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Irreversible Electroporation (Ire)
Non-Thermal Ablation
Market segment by Application can be divided into
Brain Cancer
Brown
Colorectal Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
The key market players for global Cancer Ablation Devices market are listed below:
Alfresa Pharma Corp.
AngioDynamics, Inc.
BTG plc (Galil Medical Ltd./Perseon Medical)
Biomedical S.r.l.
Boston Scientific Corporation
CSA Medical, Inc.
Chongqing Haifu Medical Technology Co., Ltd
ECO Medical
EDAP TMS S.A.
HS Hospital Service S.p.A.
IceCure Medical, Inc.
Johnson & Johnson (Ethicon, Inc.)
Kang-Yu Medical Co., Ltd.
MedLink Technologies LLC
MedWaves, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Ablation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Ablation Devices, with price, sales, revenue and global market share of Cancer Ablation Devices from 2019 to 2022.
Chapter 3, the Cancer Ablation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Ablation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Ablation Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Ablation Devices.
Chapter 13, 14, and 15, to describe Cancer Ablation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Cancer Ablation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Ablation Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cryoablation
1.2.3 High-Intensity Focused Ultrasound (HIFU)
1.2.4 Laser Interstitial Thermal Therapy (LiTT)
1.2.5 Microwave Ablation (MWA)
1.2.6 Radiofrequency Ablation (RFA)
1.2.7 Irreversible Electroporation (Ire)
1.2.8 Non-Thermal Ablation
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Ablation Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Brain Cancer
1.3.3 Brown
1.3.4 Colorectal Cancer
1.3.5 Kidney Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Pancreatic Cancer
1.3.9 Prostate Cancer
1.4 Global Cancer Ablation Devices Market Size & Forecast
1.4.1 Global Cancer Ablation Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Ablation Devices Sales in Volume (2017-2028)
1.4.3 Global Cancer Ablation Devices Price (2017-2028)
1.5 Global Cancer Ablation Devices Production Capacity Analysis
1.5.1 Global Cancer Ablation Devices Total Production Capacity (2017-2028)
1.5.2 Global Cancer Ablation Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Ablation Devices Market Drivers
1.6.2 Cancer Ablation Devices Market Restraints
1.6.3 Cancer Ablation Devices Trends Analysis
2 Manufacturers Profiles
2.1 Alfresa Pharma Corp.
2.1.1 Alfresa Pharma Corp. Details
2.1.2 Alfresa Pharma Corp. Major Business
2.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Product and Services
2.1.4 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AngioDynamics, Inc.
2.2.1 AngioDynamics, Inc. Details
2.2.2 AngioDynamics, Inc. Major Business
2.2.3 AngioDynamics, Inc. Cancer Ablation Devices Product and Services
2.2.4 AngioDynamics, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BTG plc (Galil Medical Ltd./Perseon Medical)
2.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Details
2.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Major Business
2.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product and Services
2.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biomedical S.r.l.
2.4.1 Biomedical S.r.l. Details
2.4.2 Biomedical S.r.l. Major Business
2.4.3 Biomedical S.r.l. Cancer Ablation Devices Product and Services
2.4.4 Biomedical S.r.l. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific Corporation
2.5.1 Boston Scientific Corporation Details
2.5.2 Boston Scientific Corporation Major Business
2.5.3 Boston Scientific Corporation Cancer Ablation Devices Product and Services
2.5.4 Boston Scientific Corporation Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CSA Medical, Inc.
2.6.1 CSA Medical, Inc. Details
2.6.2 CSA Medical, Inc. Major Business
2.6.3 CSA Medical, Inc. Cancer Ablation Devices Product and Services
2.6.4 CSA Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chongqing Haifu Medical Technology Co., Ltd
2.7.1 Chongqing Haifu Medical Technology Co., Ltd Details
2.7.2 Chongqing Haifu Medical Technology Co., Ltd Major Business
2.7.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product and Services
2.7.4 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 ECO Medical
2.8.1 ECO Medical Details
2.8.2 ECO Medical Major Business
2.8.3 ECO Medical Cancer Ablation Devices Product and Services
2.8.4 ECO Medical Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 EDAP TMS S.A.
2.9.1 EDAP TMS S.A. Details
2.9.2 EDAP TMS S.A. Major Business
2.9.3 EDAP TMS S.A. Cancer Ablation Devices Product and Services
2.9.4 EDAP TMS S.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 HS Hospital Service S.p.A.
2.10.1 HS Hospital Service S.p.A. Details
2.10.2 HS Hospital Service S.p.A. Major Business
2.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Product and Services
2.10.4 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 IceCure Medical, Inc.
2.11.1 IceCure Medical, Inc. Details
2.11.2 IceCure Medical, Inc. Major Business
2.11.3 IceCure Medical, Inc. Cancer Ablation Devices Product and Services
2.11.4 IceCure Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Johnson & Johnson (Ethicon, Inc.)
2.12.1 Johnson & Johnson (Ethicon, Inc.) Details
2.12.2 Johnson & Johnson (Ethicon, Inc.) Major Business
2.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product and Services
2.12.4 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Kang-Yu Medical Co., Ltd.
2.13.1 Kang-Yu Medical Co., Ltd. Details
2.13.2 Kang-Yu Medical Co., Ltd. Major Business
2.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product and Services
2.13.4 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MedLink Technologies LLC
2.14.1 MedLink Technologies LLC Details
2.14.2 MedLink Technologies LLC Major Business
2.14.3 MedLink Technologies LLC Cancer Ablation Devices Product and Services
2.14.4 MedLink Technologies LLC Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 MedWaves, Inc.
2.15.1 MedWaves, Inc. Details
2.15.2 MedWaves, Inc. Major Business
2.15.3 MedWaves, Inc. Cancer Ablation Devices Product and Services
2.15.4 MedWaves, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Ablation Devices Breakdown Data by Manufacturer
3.1 Global Cancer Ablation Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Ablation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Ablation Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Ablation Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Ablation Devices Manufacturer Market Share in 2021
3.5 Global Cancer Ablation Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Ablation Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Ablation Devices Market Size by Region
4.1.1 Global Cancer Ablation Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Ablation Devices Revenue by Region (2017-2028)
4.2 North America Cancer Ablation Devices Revenue (2017-2028)
4.3 Europe Cancer Ablation Devices Revenue (2017-2028)
4.4 Asia-Pacific Cancer Ablation Devices Revenue (2017-2028)
4.5 South America Cancer Ablation Devices Revenue (2017-2028)
4.6 Middle East and Africa Cancer Ablation Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Ablation Devices Sales in Volume by Type (2017-2028)
5.2 Global Cancer Ablation Devices Revenue by Type (2017-2028)
5.3 Global Cancer Ablation Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Ablation Devices Sales in Volume by Application (2017-2028)
6.2 Global Cancer Ablation Devices Revenue by Application (2017-2028)
6.3 Global Cancer Ablation Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Ablation Devices Sales by Type (2017-2028)
7.2 North America Cancer Ablation Devices Sales by Application (2017-2028)
7.3 North America Cancer Ablation Devices Market Size by Country
7.3.1 North America Cancer Ablation Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Ablation Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Ablation Devices Sales by Type (2017-2028)
8.2 Europe Cancer Ablation Devices Sales by Application (2017-2028)
8.3 Europe Cancer Ablation Devices Market Size by Country
8.3.1 Europe Cancer Ablation Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Ablation Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Ablation Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Ablation Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Ablation Devices Market Size by Region
9.3.1 Asia-Pacific Cancer Ablation Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Ablation Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Ablation Devices Sales by Type (2017-2028)
10.2 South America Cancer Ablation Devices Sales by Application (2017-2028)
10.3 South America Cancer Ablation Devices Market Size by Country
10.3.1 South America Cancer Ablation Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Ablation Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Ablation Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Ablation Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Ablation Devices Market Size by Country
11.3.1 Middle East & Africa Cancer Ablation Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Ablation Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Ablation Devices
12.3 Cancer Ablation Devices Production Process
12.4 Cancer Ablation Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Ablation Devices Typical Distributors
13.3 Cancer Ablation Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Cancer Ablation Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cancer Ablation Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Alfresa Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table 4. Alfresa Pharma Corp. Major Business
Table 5. Alfresa Pharma Corp. Cancer Ablation Devices Product and Services
Table 6. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AngioDynamics, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. AngioDynamics, Inc. Major Business
Table 9. AngioDynamics, Inc. Cancer Ablation Devices Product and Services
Table 10. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Manufacturing Base and Competitors
Table 12. BTG plc (Galil Medical Ltd./Perseon Medical) Major Business
Table 13. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product and Services
Table 14. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biomedical S.r.l. Basic Information, Manufacturing Base and Competitors
Table 16. Biomedical S.r.l. Major Business
Table 17. Biomedical S.r.l. Cancer Ablation Devices Product and Services
Table 18. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Boston Scientific Corporation Major Business
Table 21. Boston Scientific Corporation Cancer Ablation Devices Product and Services
Table 22. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. CSA Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. CSA Medical, Inc. Major Business
Table 25. CSA Medical, Inc. Cancer Ablation Devices Product and Services
Table 26. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Chongqing Haifu Medical Technology Co., Ltd Major Business
Table 29. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product and Services
Table 30. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. ECO Medical Basic Information, Manufacturing Base and Competitors
Table 32. ECO Medical Major Business
Table 33. ECO Medical Cancer Ablation Devices Product and Services
Table 34. ECO Medical Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. EDAP TMS S.A. Basic Information, Manufacturing Base and Competitors
Table 36. EDAP TMS S.A. Major Business
Table 37. EDAP TMS S.A. Cancer Ablation Devices Product and Services
Table 38. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. HS Hospital Service S.p.A. Basic Information, Manufacturing Base and Competitors
Table 40. HS Hospital Service S.p.A. Major Business
Table 41. HS Hospital Service S.p.A. Cancer Ablation Devices Product and Services
Table 42. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. IceCure Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. IceCure Medical, Inc. Major Business
Table 45. IceCure Medical, Inc. Cancer Ablation Devices Product and Services
Table 46. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Johnson & Johnson (Ethicon, Inc.) Basic Information, Manufacturing Base and Competitors
Table 48. Johnson & Johnson (Ethicon, Inc.) Major Business
Table 49. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product and Services
Table 50. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Kang-Yu Medical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Kang-Yu Medical Co., Ltd. Major Business
Table 53. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product and Services
Table 54. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. MedLink Technologies LLC Basic Information, Manufacturing Base and Competitors
Table 56. MedLink Technologies LLC Major Business
Table 57. MedLink Technologies LLC Cancer Ablation Devices Product and Services
Table 58. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. MedWaves, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. MedWaves, Inc. Major Business
Table 61. MedWaves, Inc. Cancer Ablation Devices Product and Services
Table 62. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Cancer Ablation Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Cancer Ablation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Cancer Ablation Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Cancer Ablation Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Cancer Ablation Devices Production Site of Key Manufacturer
Table 68. Cancer Ablation Devices New Entrant and Capacity Expansion Plans
Table 69. Cancer Ablation Devices Mergers & Acquisitions in the Past Five Years
Table 70. Global Cancer Ablation Devices Sales by Region (2017-2022) & (K Units)
Table 71. Global Cancer Ablation Devices Sales by Region (2023-2028) & (K Units)
Table 72. Global Cancer Ablation Devices Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Cancer Ablation Devices Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 75. Global Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 76. Global Cancer Ablation Devices Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Cancer Ablation Devices Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Cancer Ablation Devices Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Cancer Ablation Devices Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 81. Global Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 82. Global Cancer Ablation Devices Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Cancer Ablation Devices Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Cancer Ablation Devices Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Cancer Ablation Devices Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 87. North America Cancer Ablation Devices Sales by Country (2023-2028) & (K Units)
Table 88. North America Cancer Ablation Devices Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Cancer Ablation Devices Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 91. North America Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 92. North America Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 93. North America Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 94. Europe Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 95. Europe Cancer Ablation Devices Sales by Country (2023-2028) & (K Units)
Table 96. Europe Cancer Ablation Devices Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Cancer Ablation Devices Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 99. Europe Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 100. Europe Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 101. Europe Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Cancer Ablation Devices Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Cancer Ablation Devices Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Cancer Ablation Devices Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Cancer Ablation Devices Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 110. South America Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)
Table 111. South America Cancer Ablation Devices Sales by Country (2023-2028) & (K Units)
Table 112. South America Cancer Ablation Devices Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Cancer Ablation Devices Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 115. South America Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 116. South America Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 117. South America Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Cancer Ablation Devices Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Cancer Ablation Devices Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Cancer Ablation Devices Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Cancer Ablation Devices Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Cancer Ablation Devices Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Cancer Ablation Devices Sales by Application (2023-2028) & (K Units)
Table 126. Cancer Ablation Devices Raw Material
Table 127. Key Manufacturers of Cancer Ablation Devices Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Cancer Ablation Devices Typical Distributors
Table 131. Cancer Ablation Devices Typical Customers
List of Figures
Figure 1. Cancer Ablation Devices Picture
Figure 2. Global Cancer Ablation Devices Revenue Market Share by Type in 2021
Figure 3. Cryoablation
Figure 4. High-Intensity Focused Ultrasound (HIFU)
Figure 5. Laser Interstitial Thermal Therapy (LiTT)
Figure 6. Microwave Ablation (MWA)
Figure 7. Radiofrequency Ablation (RFA)
Figure 8. Irreversible Electroporation (Ire)
Figure 9. Non-Thermal Ablation
Figure 10. Global Cancer Ablation Devices Revenue Market Share by Application in 2021
Figure 11. Brain Cancer
Figure 12. Brown
Figure 13. Colorectal Cancer
Figure 14. Kidney Cancer
Figure 15. Liver Cancer
Figure 16. Lung Cancer
Figure 17. Pancreatic Cancer
Figure 18. Prostate Cancer
Figure 19. Global Cancer Ablation Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 20. Global Cancer Ablation Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 21. Global Cancer Ablation Devices Sales (2017-2028) & (K Units)
Figure 22. Global Cancer Ablation Devices Price (2017-2028) & (US$/Unit)
Figure 23. Global Cancer Ablation Devices Production Capacity (2017-2028) & (K Units)
Figure 24. Global Cancer Ablation Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 25. Cancer Ablation Devices Market Drivers
Figure 26. Cancer Ablation Devices Market Restraints
Figure 27. Cancer Ablation Devices Market Trends
Figure 28. Global Cancer Ablation Devices Sales Market Share by Manufacturer in 2021
Figure 29. Global Cancer Ablation Devices Revenue Market Share by Manufacturer in 2021
Figure 30. Cancer Ablation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 31. Top 3 Cancer Ablation Devices Manufacturer (Revenue) Market Share in 2021
Figure 32. Top 6 Cancer Ablation Devices Manufacturer (Revenue) Market Share in 2021
Figure 33. Global Cancer Ablation Devices Sales Market Share by Region (2017-2028)
Figure 34. Global Cancer Ablation Devices Revenue Market Share by Region (2017-2028)
Figure 35. North America Cancer Ablation Devices Revenue (2017-2028) & (USD Million)
Figure 36. Europe Cancer Ablation Devices Revenue (2017-2028) & (USD Million)
Figure 37. Asia-Pacific Cancer Ablation Devices Revenue (2017-2028) & (USD Million)
Figure 38. South America Cancer Ablation Devices Revenue (2017-2028) & (USD Million)
Figure 39. Middle East & Africa Cancer Ablation Devices Revenue (2017-2028) & (USD Million)
Figure 40. Global Cancer Ablation Devices Sales Market Share by Type (2017-2028)
Figure 41. Global Cancer Ablation Devices Revenue Market Share by Type (2017-2028)
Figure 42. Global Cancer Ablation Devices Price by Type (2017-2028) & (US$/Unit)
Figure 43. Global Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 44. Global Cancer Ablation Devices Revenue Market Share by Application (2017-2028)
Figure 45. Global Cancer Ablation Devices Price by Application (2017-2028) & (US$/Unit)
Figure 46. North America Cancer Ablation Devices Sales Market Share by Type (2017-2028)
Figure 47. North America Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 48. North America Cancer Ablation Devices Sales Market Share by Country (2017-2028)
Figure 49. North America Cancer Ablation Devices Revenue Market Share by Country (2017-2028)
Figure 50. United States Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Cancer Ablation Devices Sales Market Share by Type (2017-2028)
Figure 54. Europe Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 55. Europe Cancer Ablation Devices Sales Market Share by Country (2017-2028)
Figure 56. Europe Cancer Ablation Devices Revenue Market Share by Country (2017-2028)
Figure 57. Germany Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Cancer Ablation Devices Sales Market Share by Region (2017-2028)
Figure 63. Asia-Pacific Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Cancer Ablation Devices Sales Market Share by Region (2017-2028)
Figure 65. Asia-Pacific Cancer Ablation Devices Revenue Market Share by Region (2017-2028)
Figure 66. China Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Korea Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Cancer Ablation Devices Sales Market Share by Type (2017-2028)
Figure 73. South America Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 74. South America Cancer Ablation Devices Sales Market Share by Country (2017-2028)
Figure 75. South America Cancer Ablation Devices Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East & Africa Cancer Ablation Devices Sales Market Share by Type (2017-2028)
Figure 79. Middle East & Africa Cancer Ablation Devices Sales Market Share by Application (2017-2028)
Figure 80. Middle East & Africa Cancer Ablation Devices Sales Market Share by Region (2017-2028)
Figure 81. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Region (2017-2028)
Figure 82. Turkey Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Egypt Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. South Africa Cancer Ablation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Manufacturing Cost Structure Analysis of Cancer Ablation Devices in 2021
Figure 87. Manufacturing Process Analysis of Cancer Ablation Devices
Figure 88. Cancer Ablation Devices Industrial Chain
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
Figure 90. Methodology
Figure 91. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがん焼灼療法機器市場2022年：冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション(Global Cancer Ablation Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp